Cardiovascular Proteomics

  title={Cardiovascular Proteomics},
  author={Melanie Y. White and Jennifer E. Van Eyk},
  journal={Molecular Diagnosis & Therapy},
With cardiovascular (CV)-related disorders accounting for the highest mortality rates in the world, affecting the quantity and quality of life of patients and creating an economic burden of prolonged therapeutic intervention, there is great significance in understanding the cellular and molecular alterations that influence the progression of these pathologies. The cellular genotype is regulated by the DNA component, whilst the cellular phenotype is influenced by the protein complement. By… CONTINUE READING

Figures and Tables from this paper.


Publications referenced by this paper.

Apolipoprotein C-II is a novel substrate for matrix metalloproteinases.

Cardiac troponin I is modified in the tioning : mechanisms and therapeutic potentials

  • PR Crisostomo, GM Wairiuko, +3 authors W Pickett
  • J Am Coll Surg
  • 2006

Impaired diastolic function after exchange identified in mitochondrial proteins by comparative proteomics . Proteomics of endogenous troponin I with C - terminal truncated troponin I in human cardiac

  • NA Narolska, N Piroddi, A Belus
  • 2006

Proteomic analysis of Rac 1 in

  • F Rezaee, B Casetta, +3 authors MA Sussman
  • Proteomics
  • 2006